Lusay, Aida D.

HRN: 22-00-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFTRIAXONE 1G (VIAL)
09/29/2022
10/02/2022
IV
2g
Q 24H
S/P Debridement Of Foot
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: